People: Vanda Pharmaceuticals Inc (VNDA.O)

VNDA.O on Consolidated Issue listed on NASDAQ Global Market

13.92USD
24 Jul 2014
Price Change (% chg)

$-0.14 (-1.00%)
Prev Close
$14.06
Open
$14.07
Day's High
$14.44
Day's Low
$13.85
Volume
259,183
Avg. Vol
852,995
52-wk High
$19.25
52-wk Low
$5.70

Search Stocks

Galson, Steven 

Brief Biography

Dr. Steven K. Galson, M.D., serves as Independent Director of Vanda Pharmaceuticals Inc., since July 1, 2010. Dr. Galson is the Vice President for Global Regulatory Affairs at Amgen, a biopharmaceuticals company. Prior to Amgen, Dr. Galson was Senior Vice President for Civilian Health Operations at Science Applications International Corporation (“SAIC”), a scientific, engineering and technology applications company. Prior to joining SAIC, Dr. Galson was the Acting U.S. Surgeon General. Prior to that, Dr. Galson was the Director of the Food and Drug Administration’s Center for Drug Evaluation and Research. Dr. Galson also held executive positions in the U.S. Environmental Protection Agency, U.S. Department of Energy and the Centers for Disease Control and Prevention’s National Institute for Occupational Safety and Health. Dr. Galson received his Bachelor of Science degree in biochemistry from the State University of New York at Stony Brook, his Doctor of Medicine degree from the Mt. Sinai School of Medicine and his Master of Public Health degree from the Harvard School of Public Health.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Howard Pien

--

Mihael Polymeropoulos

2,520,230

James Kelly

1,145,380

Paolo Baroldi

1,111,410

Michael Cola

--

Richard Dugan

--
As Of 30 Dec 2013
Search Stocks